Inventor
KINOSHITA TAISEI
US15 patents
⚠️ This page may combine multiple inventors who share the name “KINOSHITA TAISEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
12 patentsUS6979549B2Dec 27, 2005
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
RIGEL PHARMACEUTICALS INC5 citations73
US7378251B2May 27, 2008
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein
RIGEL PHARMACEUTICALS INC2 citations62
US7482351B2Jan 27, 2009
4-pyrimidineamine compounds and their uses as anti-proliferative agents
RIGEL PHARMACEUTICALS INC2 citations61
US8377945B2Feb 19, 2013
Small molecule inhibitors of spleen tyrosine kinase (SYK)
RIGEL PHARMACEUTICALS INC1 citations52
US7598050B2Oct 6, 2009
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
RIGEL PHARMACEUTICALS INC1 citations51
US7563585B2Jul 21, 2009
Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)
RIGEL PHARMACEUTICALS INC0 citations51
US7422867B2Sep 9, 2008
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
RIGEL PHARMACEUTICALS INC0 citations51
US7374894B2May 20, 2008
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
RIGEL PHARMACEUTICALS INC0 citations51
US7241581B2Jul 10, 2007
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein
RIGEL PHARMACEUTICALS INC0 citations51
US7208289B2Apr 24, 2007
Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
RIGEL PHARMACEUTICALS INC0 citations51
US7189523B2Mar 13, 2007
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein
RIGEL PHARMACEUTICALS INC0 citations51
US7141434B2Nov 28, 2006
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase
RIGEL PHARMACEUTICALS INC0 citations51